Cargando…
Potential Development of Tumor-Targeted Oral Anti-Cancer Prodrugs: Amino Acid and Dipeptide Monoester Prodrugs of Gemcitabine
One of the main obstacles for cancer therapies is to deliver medicines effectively to target sites. Since stroma cells are developed around tumors, chemotherapeutic agents have to go through stroma cells in order to reach tumors. As a method to improve drug delivery to the tumor site, a prodrug appr...
Autores principales: | Tsume, Yasuhiro, Drelich, Adam J., Smith, David E., Amidon, Gordon L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5826767/ https://www.ncbi.nlm.nih.gov/pubmed/28796151 http://dx.doi.org/10.3390/molecules22081322 |
Ejemplares similares
-
The Dipeptide Monoester Prodrugs of Floxuridine and Gemcitabine—Feasibility of Orally Administrable Nucleoside Analogs
por: Tsume, Yasuhiro, et al.
Publicado: (2014) -
The Feasibility of Enzyme Targeted Activation for Amino Acid/Dipeptide Monoester Prodrugs of Floxuridine; Cathepsin D as a Potential Targeted Enzym
por: Tsume, Yasuhiro, et al.
Publicado: (2012) -
Enhanced Absorption and Growth Inhibition with Amino Acid Monoester Prodrugs of Floxuridine by Targeting hPEPT1 Transporters
por: Tsume, Yasuhiro, et al.
Publicado: (2008) -
Enhanced Cancer Cell Growth Inhibition by Dipeptide Prodrugs of Floxuridine: Increased Transporter Affinity and Metabolic Stability
por: Tsume, Yasuhiro, et al.
Publicado: (2008) -
Synthesis and Antibacterial Activity of Amino Acid and Dipeptide Prodrugs of IMB-070593, a Fluoroquinolone Candidate
por: Zhang, Tingting, et al.
Publicado: (2014)